48,860
edits
Difference between revisions of "Endometrial carcinoma"
Jump to navigation
Jump to search
Endometrial carcinoma (view source)
Revision as of 14:28, 4 September 2015
, 14:28, 4 September 2015→IHC
(→IHC) |
(→IHC) |
||
| Line 177: | Line 177: | ||
*CK20 -ve.<ref name=pmid11444201/> | *CK20 -ve.<ref name=pmid11444201/> | ||
*Vimentin +ve.<ref name=pmid11444201/> | *Vimentin +ve.<ref name=pmid11444201/> | ||
*Napsin A +ve.<ref name=pmid25971546>{{Cite journal | last1 = Iwamoto | first1 = M. | last2 = Nakatani | first2 = Y. | last3 = Fugo | first3 = K. | last4 = Kishimoto | first4 = T. | last5 = Kiyokawa | first5 = T. | title = Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. | journal = Hum Pathol | volume = 46 | issue = 7 | pages = 957-62 | month = Jul | year = 2015 | doi = 10.1016/j.humpath.2015.03.008 | PMID = 25971546 }}</ref> | |||
Note: | Note: | ||